Yuekun Qi

4PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 21, 2026
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.

|Aug 28, 2024
Clinical outcomes and microenvironment profiling in relapsed/refractory multiple myeloma patients with extramedullary disease receiving anti-BCMA CAR T-cell-based therapy.

Yuekun Qi, Hujun Li, Kunming Qi

|Mar 07, 2023
Anti-G Protein-Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial.

Jieyun Xia, Hujun Li, Zhiling Yan

|Mar 26, 2022
Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients with CNSL.

Yuekun Qi, Mingfeng Zhao, Yongxian Hu

Pageof 1

Frequent Collaborators

3 joint publications

Jiang Cao

3 joint publications

Kailin Xu

3 joint publications

Wei Chen

2 joint publications

Jianlin Qiao